Skip to content
Anti-Kickback Defense
Research TopicsStatute ExplainedRecent DecisionsStatesCitiesFAQAbout
Browse the Archive
Home Research TopicsStatute ExplainedRecent DecisionsStatesCitiesFAQAbout Browse the Archive
Home/Research/Upcoding, Phantom Billing, and Tainted Claims

Upcoding, Phantom Billing, and Tainted Claims

By John D. Kirby — Author and Publisher

Understanding the legal implications of upcoding, phantom billing, and tainted claims under the Anti-Kickback Statute.

Upcoding, Phantom Billing, and Tainted Claims at a Glance

Upcoding, phantom billing, and tainted claims are billing practices that can cross into the realm of legal violations under the Anti-Kickback Statute (AKS). These practices involve misrepresenting the nature or extent of medical services provided, or billing for services not rendered, which can lead to criminal liability and False Claims Act (FCA) exposure. Under 42 U.S.C. § 1320a-7b(g), any claim that includes items or services resulting from an AKS violation is considered a false or fraudulent claim under the FCA. This legal connection transforms billing violations into potential federal enforcement actions with significant penalties and qui tam relator incentives.

The Legal Framework

The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), criminalizes the knowing and willful offer, payment, solicitation, or receipt of remuneration to induce or reward referrals of items or services payable by a federal health care program. Violations can result in fines of up to $100,000 or imprisonment of up to 10 years, or both. This statute is particularly relevant to billing schemes such as upcoding and phantom billing, which may be used to inflate reimbursement or secure improper referrals.

Under 42 U.S.C. § 1320a-7b(g), any claim that incorporates items or services arising from an AKS violation is deemed a false or fraudulent claim for purposes of the False Claims Act (31 U.S.C. ch. 37, subch. III). This provision links AKS violations directly to FCA liability, significantly increasing the legal exposure for providers and entities involved in improper billing practices.

The False Claims Act (31 U.S.C. §§ 3729–3733) provides a legal mechanism for qui tam relators to bring actions on behalf of the government. Relators may receive between 15-25% of the proceeds if the government proceeds with the action, 25-30% if the government declines, and no more than 10% if the action is based primarily on public disclosures. This structure incentivizes private individuals to report billing violations, including those tied to upcoding, phantom billing, or other AKS-related schemes.

The Federal Overlay

The federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), makes it a felony to knowingly and willfully offer, pay, solicit, or receive remuneration to induce or reward referrals of items or services payable by a federal health care program. The Stark Law, 42 U.S.C. § 1395nn, separately prohibits physician self-referrals for designated health services payable by Medicare or Medicaid, on strict-liability terms. Both regimes carry safe harbors and exceptions published at 42 C.F.R. § 1001.952. State referral and fee-splitting statutes operate alongside these federal prohibitions and can apply even where no federal program payment is involved.

Reading the Research Desk

To explore related topics further, visit our AKS Defense Research Topics desk, our statute explainer, our safe-harbor research note, our AKS/Stark overlap analysis, our recent decisions, or our FAQ.

About the Research Desk

Anti-Kickback Defense publishes editorial legal research, public-record summaries, and statute-level analysis only.

Editorial Policy

No attorney persona, no client-matching copy, no fake reviews, and no consultation CTAs appear on this site.

Citations Notice

Readers should verify cases, statutes, and procedural rules before relying on any summary.

Related: About Healthcare Fraud Research Desk — Healthcare Fraud Research Desk — About Healthcare Fraud Research Desk — Healthcare Fraud Research Desk Healthcare Fraud Research Desk Home About Research

Related Pages

  • Elements of a Referral Kickback Under 42 U.S.C. § 1320a-7b(b) | Anti-Kickback Defense — defense, kickback, fraud
  • The Anti-Kickback Statute Explained | Anti-Kickback Defense — defense, kickback, fraud

Related: About Healthcare Fraud Research Desk — Healthcare Fraud Research Desk — About Healthcare Fraud Research Desk — Healthcare Fraud Research Desk Healthcare Fraud Research Desk Home About Research

Anti-Kickback Defense

Editorial legal research on the Anti-Kickback Statute, Stark Law, and compliance investigations.

Site

  • Research Topics
  • FAQ
  • Depth
  • Terms

Research

  • States
  • About
  • Dispatches
  • Privacy

Legal

  • Cities
  • Contact
  • Archive

Anti-Kickback Defense publishes editorial legal research and public-record summaries. Nothing on this site is legal advice, and no attorney-client relationship is formed by reading it.

Citations notice: Readers should verify cases, statutes, and procedural rules before relying on any summary.

© 2026 Anti-Kickback Defense. Editorial policy: no attorney persona, no client-matching copy, no consultation CTAs.